Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 2:29 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 961–984 of 13,929 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Gingival Recession
Interventions: Acellular Dermal Matrix; Biological
Lead sponsor: Tufts University; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Abnormal Uterine Bleeding, Analgesia, Paracervical Block
Interventions: paracervical block, Lidocaine, ketorolac; Procedure · Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Psoriasis
Interventions: JNJ-38518168 60 mg, JNJ-38518168 30 mg, JNJ-38518168 3 mg, Placebo; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 10
States / cities: Los Angeles, California • Santa Monica, California • Atlanta, Georgia + 7 more

Conditions: Tissue Grafts
Interventions: Tissue Matrix Graft Placement, No Stitches; Procedure
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older · Male only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Pediatric, Well Child Care
Interventions: Adapted PARENT Model; Other
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 9 Months to 15 Months
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 3
States / cities: Honolulu, Hawaii • Columbus, Ohio • Seattle, Washington

Conditions: Arterial Catheterization
Interventions: Lidocaine/tetracaine patch, Placebo Patch, Subcutaneous injection of 0.5 ml Lidocain 1%, Subcutaneous injection of saline; Drug
Lead sponsor: Medical University of Vienna; Other
Eligibility: 18 Years to 90 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Arthritis of Carpometacarpal Joint of Left Thumb, Arthritis of Carpometacarpal Joint of Right Thumb
Interventions: Curcumin, Placebo; Drug
Lead sponsor: Brent DeGeorge; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Memory Impairment
Interventions: Donepezil, Placebo; Drug
Lead sponsor: Porter Adventist Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Epilepsy
Interventions: UPLIFT (Using Practice and Learning to Increase Favorable Thoughts), BOOST (Bringing Out Our Strength Together); Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 99 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Diffuse Cutaneous Systemic Sclerosis, Scleroderma, dcSSc
Interventions: Brentuximab Vedotin, Placebo; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 70 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 8
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Ann Arbor, Michigan + 5 more

Conditions: Myasthaenia Gravis
Interventions: Decartes-08, Placebo Drug; Biological · Other
Lead sponsor: Cartesian Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 23
States / cities: Tucson, Arizona • Carlsbad, California • Los Angeles, California + 19 more

Conditions: Osteoarthritis
Interventions: LY3556050, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 40 Years and older
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 38
States / cities: Birmingham, Alabama • Chandler, Arizona • Glendale, Arizona + 32 more

Conditions: Postpartum Depression (PPD)
Interventions: SAINT Neuromodulation System, Sham SAINT Stimulation; Device
Lead sponsor: Magnus Medical; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 4
States / cities: Worcester, Massachusetts • New York, New York • Charleston, South Carolina + 1 more

Conditions: Cytomegalovirus Infection
Interventions: DBS Self-Collection Kit, Standard Control Strategy; Device · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 15 Years to 99 Years
Enrollment: 622 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 4
States / cities: Minneapolis, Minnesota • New York, New York • Houston, Texas + 1 more

Conditions: Crime, Juvenile Delinquency
Interventions: Big Brothers Big Sisters Community-Based Mentoring Program; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 10 Years and older
Enrollment: 1,361 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Antimicrobial Prescribing Practices
Interventions: Academic Detailing by the Antimicrobial Utilization Team (AUT); Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 85 Years
Enrollment: 785 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2003
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Pulmonary Hypertension, Valvular Heart Disease, Congenital Heart Disease, Congestive Heart Failure, Pulmonary Embolism, Acute Coronary Syndrome
Interventions: Measuring Right Ventricular Size and Function; Diagnostic Test
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Atopic Dermatitis
Interventions: Tralokinumab, Placebo; Drug
Lead sponsor: LEO Pharma; Industry
Eligibility: 18 Years and older
Enrollment: 794 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 40
States / cities: Hot Springs, Arkansas • Encinitas, California • Fullerton, California + 35 more

Conditions: Biliary Obstruction Due to Common Bile Duct Stone, Malignant Bile Duct Obstruction
Interventions: Needle Knife Fistulotomy, standard biliary cannulation; Procedure
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Stress Disorders, Post-Traumatic
Interventions: Doxazosin Mesylate, Extended Release, Placebo; Drug
Lead sponsor: San Francisco Veterans Affairs Medical Center; Federal
Eligibility: 18 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pregnancy
Interventions: levonorgestrel 0.75mg taken twice 12 hours apart (Plan B) and condoms; Drug
Lead sponsor: University of Washington; Other
Eligibility: 16 Years to 60 Years · Female only
Enrollment: 177 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: COVID-19
Interventions: SMARTest mobile app for COVID-19 self-testing; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: ACL, Anterior Cruciate Ligament Injuries
Interventions: Genicular Nerve Block with bupivacaine and preservative free dexamethasone; Drug
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years to 80 Years
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Chronic Pain, Hypertension, Implanted Stimulation Electrodes
Interventions: Diagnostic Tests; Diagnostic Test
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 30 Years to 89 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 2
States / cities: Fairway, Kansas • Kansas City, Kansas

Search by objective public record fields.

A Clinical Trial Testing Root Coverage With Acellular Dermal Matrix in Thin and Thick Gingival Biotypes

Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy

A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis

Buccal Mucosa Healing Trial With Tissue Matrix Placement

Comparing a Team-Based Approach to Standard Well-Child Visits To Improve Preventive Care Services

Rapydan Topical Anaesthesia for Arterial Cannulation

Oral Curcumin for the Treatment of Pain of Thumb Base Joint (CMC) Arthritis

Donepezil Memory Preservation Post ECT

Telephone-Based Support Programs for People With Epilepsy

Brentuximab Vedotin for Systemic Sclerosis

Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis

Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Osteoarthritis

SAINT in Postpartum Depression (PPD)

Dried Blood Spot Testing of CMV Detection in HCT Recipients

Randomized Controlled Trial of Big Brothers Big Sisters Mentoring for Prevention of Crime and Delinquency

The Impact of an Antimicrobial Utilization Program on Antimicrobial Use

Evaluating Right Ventricular (RV) Size and Function Using the Upper Valley RV Algorithm and Novel Imaging Modalities

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)

Needle-Knife Fistulotomy Vs. Standard Cannulation Trial

A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD

Randomized Trial of Advanced Provision Emergency Contraception Among Women With Gonorrhea or Chlamydia

COVID-19 Self-testing Study

Genicular Nerve Blocks for Anterior Cruciate Ligament Knee Surgery

Epidural Spinal Cord Stimulation for Hypertension in Patients With Neuropathic Pain